James Condulis
Stock Analyst at Stifel Nicolaus
(3.32)
# 2,479
Out of 4,703 analysts
56
Total ratings
53.2%
Success rate
7.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Condulis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARWR Arrowhead Pharmaceuticals | Maintained: Buy | $104 | $86.34 | +20.45% | 3 | Aug 31, 2026 | |
| BRVE Braveheart Bio | Initiated Coverage: Buy | $45 | $26.74 | +68.29% | 1 | Aug 31, 2026 | |
| AMLX Amylyx Pharmaceuticals | Reiterated: Buy | n/a | $34.10 | - | 2 | Aug 18, 2026 | |
| AARD Aardvark Therapeutics | Reiterated: Hold | $6 | $5.38 | +11.52% | 5 | Aug 13, 2026 | |
| EWTX Edgewise Therapeutics | Maintained: Hold | $36 | $43.07 | -16.42% | 6 | Aug 11, 2026 | |
| CYTK Cytokinetics | Reiterated: Buy | $108 | $72.72 | +48.51% | 16 | Aug 7, 2026 | |
| XFOR X4 Pharmaceuticals | Maintained: Buy | $10 | $4.04 | +147.52% | 2 | Aug 7, 2026 | |
| TECX Tectonic Therapeutic | Maintained: Buy | $75 | $30.75 | +143.90% | 3 | Aug 7, 2026 | |
| MIRM Mirum Pharmaceuticals | Maintained: Buy | $136 | $100.90 | +34.79% | 8 | Aug 6, 2026 | |
| NAMS NewAmsterdam Pharma Company | Reiterated: Buy | $50 | $25.40 | +96.85% | 5 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $25 → $3 | $3.85 | -22.08% | 5 | Jun 2, 2026 |
Arrowhead Pharmaceuticals
Aug 31, 2026
Maintained: Buy
Price Target: $104
Current: $86.34
Upside: +20.45%
Braveheart Bio
Aug 31, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $26.74
Upside: +68.29%
Amylyx Pharmaceuticals
Aug 18, 2026
Reiterated: Buy
Price Target: n/a
Current: $34.10
Upside: -
Aardvark Therapeutics
Aug 13, 2026
Reiterated: Hold
Price Target: $6
Current: $5.38
Upside: +11.52%
Edgewise Therapeutics
Aug 11, 2026
Maintained: Hold
Price Target: $36
Current: $43.07
Upside: -16.42%
Cytokinetics
Aug 7, 2026
Reiterated: Buy
Price Target: $108
Current: $72.72
Upside: +48.51%
X4 Pharmaceuticals
Aug 7, 2026
Maintained: Buy
Price Target: $10
Current: $4.04
Upside: +147.52%
Tectonic Therapeutic
Aug 7, 2026
Maintained: Buy
Price Target: $75
Current: $30.75
Upside: +143.90%
Mirum Pharmaceuticals
Aug 6, 2026
Maintained: Buy
Price Target: $136
Current: $100.90
Upside: +34.79%
NewAmsterdam Pharma Company
Aug 6, 2026
Reiterated: Buy
Price Target: $50
Current: $25.40
Upside: +96.85%
Jun 2, 2026
Downgraded: Hold
Price Target: $25 → $3
Current: $3.85
Upside: -22.08%